| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $157K | +0.1% |
| SG&A Expense | $64K | -42.0% |
| Operating Income | -$666K | +45.6% |
| Income Tax | $0 | — |
| Net Income | -$999K | +45.5% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $180K | -30.7% |
| Accounts Receivable | $6K | -37.5% |
| Current Assets | $332K | -75.4% |
| Total Assets | $343K | -74.8% |
| Total Liabilities | $316K | -5.0% |
| Stockholders' Equity | $28K | -97.3% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$666K | +45.1% |
| Investing Cash Flow | $586K | -31.4% |
| Financing Cash Flow | $0 | -100.0% |